Mycobacterium avium complex disease
MONDO:0005866An infection that is caused by Mycobacterium avium.
Also known as: Mycobacterium avium Complex, Mycobacterium avium complex caused disease or disorder, Mycobacterium avium complex disease or disorder, Mycobacterium avium complex infectious disease, Mycobacterium avium infection, DMAC, disseminated infection with mycobacterium avium complex
20 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
New hope for stubborn lung infection: bedaquiline combo shows promise
Disease control CompletedThis study tested whether adding bedaquiline to two standard antibiotics (clarithromycin and ethambutol) helps clear a stubborn lung infection called MAC lung disease. 129 adults who had not responded to previous treatment took part. The main goal was to see if the new combinatio…
Phase: PHASE2, PHASE3 • Sponsor: Janssen Pharmaceutical K.K. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Could fewer antibiotics be better for MAC lung disease?
Disease control CompletedThis study tested whether taking two antibiotics instead of three is just as effective for treating a lung infection called MAC, while causing fewer side effects. 474 adults with MAC lung disease were randomly assigned to receive either two or three drugs for 12 months. The goal …
Phase: PHASE2, PHASE3 • Sponsor: Kevin Winthrop • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Inhaled antibiotic shows promise against stubborn lung infection
Disease control CompletedThis study tested whether adding an inhaled antibiotic (ALIS) to standard oral antibiotics helps adults with a new diagnosis of a hard-to-treat lung infection caused by MAC bacteria. About 425 adults took part. The main goal was to see if the combination improved breathing sympto…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New drug combo may make bone marrow transplants safer for blood cancer patients
Disease control CompletedThis early-phase trial tested replacing the standard drug cyclophosphamide with bendamustine after a half-matched bone marrow transplant in 50 patients with various blood cancers. The goal was to see if this change could reduce side effects like graft-versus-host disease while st…
Phase: PHASE1 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New hope for stubborn lung infection? drug trial underway
Disease control CompletedThis study tested an experimental drug called SPR720 in 25 adults with a chronic lung infection caused by Mycobacterium avium complex (MAC). The goal was to see if the drug can reduce bacteria in sputum and is safe compared to a placebo. Participants took the drug or placebo by m…
Phase: PHASE2 • Sponsor: Spero Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Small study checks early bacteria-killing power of common MAC drug
Knowledge-focused CompletedThis pilot study looked at how well the antibiotic azithromycin kills Mycobacterium avium complex (MAC) bacteria in the lungs during the first 14 days of treatment. Ten adults with MAC lung disease took azithromycin daily, and researchers measured bacterial levels in their sputum…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Less gas, same safety: new anesthesia method cuts drug use in kidney stone surgery
Knowledge-focused CompletedThis study tested two ways of giving anesthesia gas (sevoflurane) during kidney stone surgery. One method used a very low gas flow (minimal-flow), the other a slightly higher flow (low-flow). In 62 adults, the minimal-flow approach used less anesthesia drug while keeping patients…
Phase: NA • Sponsor: Dr. Lutfi Kirdar Kartal Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC